https://ds.dfci.harvard.edu/wp-content/uploads/2021/09/preferred_meredith_regan_square.jpg 404 404 laura /wp-content/uploads/2020/05/dfcI_data_science.svg laura2022-06-08 14:49:392022-06-08 14:52:37Meredith M. Regan, ScD, Recognized As 2022 ASCO Fellow
Meredith M. Regan, ScD, Recognized As 2022 ASCO Fellow
Meredith M. Regan, ScD, Associate Professor, received the distinction of FASCO, “Fellow of the American Society of Clinical Oncology” during the 2022 ASCO Annual Meeting. The FASCO distinction recognizes ASCO members for their extraordinary volunteer service, dedication, and commitment to ASCO.
Dr. Regan led statistical collaboration for several studies presented at this year’s ASCO Annual Meeting, held June 3-6 in Chicago. Learn more about new breast cancer findings related to adjuvant endocrine therapy in high-risk subgroups: